Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

quality imaging appropriateness clinical decision support CAS AUC

Lawmakers urge CMS to reexamine long-delayed imaging Appropriate Use Criteria program

The quality initiative has been pushed back several times, and some are concerned that it's no longer relevant and duplicates other efforts. 

Thumbnail

Advocates applaud legislation that would improve coverage for peripheral artery disease screening

If signed into law, the bill would improve coverage for screening for both Medicare and Medicaid beneficiaries. 

Thumbnail

AHA condemns Trump administration’s latest attack on ACA

The American Heart Association noted that the Affordable Care Act has provided “invaluable patient protections for millions of Americans with pre-existing conditions.”

Thumbnail

Nuclear medicine, cardio groups reject proposed myocardial PET cuts

Multiple nuclear medicine and cardiology groups are working to oppose potential cuts to myocardial PET scans that were made possible by the CMS 2020 Medicare Physician Fee Schedule (MPFS) proposed rule, according to a joint statement.

Thumbnail

Industry groups oppose proposed myocardial PET cuts

When CMS released the 2020 Medicare Physician Fee Schedule (MPFS) proposed rule, it included revisions that could lead to technical component payment reductions of up to 80% for certain services related to myocardial PET scans.

Thumbnail

CMS proposes expanding national coverage indications for remote BP monitoring

CMS proposed to expand reimbursement for ambulatory blood pressure monitoring (ABPM) to patients with suspected masked hypertension while continuing to cover it for those with white coat hypertension.

Thumbnail

After pricing pushback, Eli Lilly will sell a half-price insulin drug

Drug manufacturer Eli Lilly plans to offer a half-priced version of its insulin medication Humalog, the company announced March 4.

Thumbnail

Erlanger Health System’s stroke program in danger after contract dispute with radiology group

A contract dispute between Chattanooga, Tennessee-based Erlanger Health System and Tennessee Interventional and Imaging Associates (TIAA) is threatening to upend the hospital’s premiere stroke program, according to documents obtained by the Times Free Press.

Around the web

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.